TFEB and Alzheimer disease: Therefore, promoting ALP, especially by targeting its master regulators TFEB/TFE3, may simultaneously rescue the ALP impairment, inhibit neuroinflammation and Aβ pathology, thus representing a fascinating strategy for the early prevention and treatment of AD [2, 7, 14].